Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
The Lancet. Respiratory medicine(2022)
摘要
LifeArc and CW+.
更多查看译文
关键词
favipiravir,patients,early intervention,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要